본문 바로가기
KERD
논문KCI 등재

Genetics of Cerebral Small Vessel Disease

Jay Chol Choi
대한뇌졸중학회 (The Korean Stroke Society)|2015.01|대한뇌졸중영문학회지 (Journal of stroke)|제17권 제1호|pp. 7-16

2

조회

0

다운로드

4

인용

0

참고문헌

키워드

Genome-wide association studyFabry diseaseGenetic association studyCerebral small vessel diseasesCADASIL
주제분류신경과학

초록

Cerebral small vessel disease (SVD) is an important cause of stroke and cognitive impairment among the elderly and is a more frequent cause of stroke in Asia than in the US or Europe. Although traditional risk factors such as hypertension or diabetes mellitus are important in the development of cerebral SVD, the exact pathogenesis is still uncertain. Both, twin and family history studies suggest heritability of sporadic cerebral SVD, while the candidate gene study and the genome-wide association study (GWAS) are mainly used in genetic research. Robust associations between the candidate genes and occurrence of various features of sporadic cerebral SVD, such as lacunar infarction, intracerebral hemorrhage, or white matter hyperintensities, have not yet been elucidated. GWAS, a relatively new technique, overcomes several shortcomings of previous genetic techniques, enabling the detection of several important genetic loci associated with cerebral SVD. In addition to the more common, sporadic cerebral SVD, several single-gene disorders causing cerebral SVD have been identified. The number of reported cases is increasing as the clinical features become clear and diagnostic examinations are more readily available. These include cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy, COL4A1-related cerebral SVD, autosomal dominant retinal vasculopathy with cerebral leukodystrophy, and Fabry disease. These rare single-gene disorders are expected to play a crucial role in our understanding of cerebral SVD pathogenesis by providing animal models for the identification of cellular, molecular, and biochemical changes underlying cerebral small vessel damage.

Abstract

Cerebral small vessel disease (SVD) is an important cause of stroke and cognitive impairment among the elderly and is a more frequent cause of stroke in Asia than in the US or Europe. Although traditional risk factors such as hypertension or diabetes mellitus are important in the development of cerebral SVD, the exact pathogenesis is still uncertain. Both, twin and family history studies suggest heritability of sporadic cerebral SVD, while the candidate gene study and the genome-wide association study (GWAS) are mainly used in genetic research. Robust associations between the candidate genes and occurrence of various features of sporadic cerebral SVD, such as lacunar infarction, intracerebral hemorrhage, or white matter hyperintensities, have not yet been elucidated. GWAS, a relatively new technique, overcomes several shortcomings of previous genetic techniques, enabling the detection of several important genetic loci associated with cerebral SVD. In addition to the more common, sporadic cerebral SVD, several single-gene disorders causing cerebral SVD have been identified. The number of reported cases is increasing as the clinical features become clear and diagnostic examinations are more readily available. These include cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy, COL4A1-related cerebral SVD, autosomal dominant retinal vasculopathy with cerebral leukodystrophy, and Fabry disease. These rare single-gene disorders are expected to play a crucial role in our understanding of cerebral SVD pathogenesis by providing animal models for the identification of cellular, molecular, and biochemical changes underlying cerebral small vessel damage.

참고문헌 (94)

  1. Pantoni L., "Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges", Lancet Neurol, 9, pp.689~701 (2010)
  2. White H, "Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan study", Circulation, 111, pp.1327~1331 (2005)
  3. Sacco S, "A population-based study of the incidence and prognosis of lacunar stroke", Neurology, 66, pp.1335~1338 (2006)
  4. Chamorro A, "Clinical-computed tomographic correlations of lacunar infarction in the Stroke Data Bank", Stroke, 22, pp.175~181 (1991)
  5. Petty GW, "Ischemic stroke subtypes: a population-based study of incidence and risk factors", Stroke, 30, pp.2513~2516 (1999)
  6. Woo D, "Incidence rates of first-ever ischemic stroke subtypes among blacks: a population-based study", Stroke, 30, pp.2517~2522 (1999)
  7. Jung KH, "Secular trends in ischemic stroke characteristics in a rapidly developed country: results from the Korean Stroke Registry Study (secular trends in Korean stroke).", Circ Cardiovasc Qual Outcomes, 5, pp.327~334 (2012)
  8. Syed NA, "Ischemic stroke subtypes in Pakistan: the Aga Khan University Stroke Data Bank", J Pak Med Assoc, 53, pp.584~588 (2003)
  9. Tsai CF, "Epidemiology of stroke and its subtypes in Chinese vs white populations: a systematic review", Neurology, 81, pp.264~272 (2013)
  10. Turin TC, "Ischemic stroke subtypes in a Japanese population: Takashima Stroke Registry, 1988-2004", Stroke, 41, pp.1871~1876 (2010)
  11. Kubo M, "Secular trends in the incidence of and risk factors for ischemic stroke and its subtypes in Japanese population", Circulation, 118, pp.2672~2678 (2008)
  12. Qureshi AI, "Intracerebral haemorrhage", Lancet, 373, pp.1632~1644 (2009)
  13. Gorelick PB, "Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American heart association", American stroke association, 2011, pp.42, 2672~2713
  14. Wardlaw JM, "Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging", Lancet Neurol, 12, pp.483~497 (2013)
  15. Lammie GA, "Nonhypertensive cerebral small-vessel disease. An autopsy study", Stroke, 28, pp.2222~2229 (1997)
  16. Meschia JF., "Ischemic stroke as a complex genetic disorder", Semin Neurol, 26, pp.49~56 (2006)
  17. Flossmann E, "Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke", Stroke, 35, pp.212~227 (2004)
  18. Polychronopoulos P, "Family history of stroke in stroke types and subtypes", J Neurol Sci, 195, pp.117~122 (2002)
  19. Jerrard-Dunne P, "Evaluating the genetic component of ischemic stroke subtypes: a family history study", Stroke, 34, pp.1364~1369 (2003)
  20. Carmelli D, "Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins", Stroke, 29, pp.1177~1181 (1998)
  21. Atwood LD, "Genetic variation in white matter hyperintensity volume in the Framingham Study", Stroke, 35, pp.1609~1613 (2004)
  22. Woo D, "Genetic and environmental risk factors for intracerebral hemorrhage: preliminary results of a population-based study", Stroke, 33, pp.1190~1195 (2002)
  23. Tabor HK, "Candidate-gene approaches for studying complex genetic traits: practical considerations", Nat Rev Genet, 3, pp.391~397 (2002)
  24. Zhang Z, "Angiotensin-converting enzyme insertion", deletion polymorphism contributes to ischemic stroke risk: a meta-analysis of 50 case-control studies, 2012, pp.7, e46495~
  25. Paternoster L, "Genetic determinants of white matter hyperintensities on brain scans: a systematic assessment of 19 candidate gene polymorphisms in 46 studies in 19,000 subjects", Stroke, 40, pp.2020~2026 (2009)
  26. Peck G, "The genetics of primary haemorrhagic stroke, subarachnoid haemorrhage and ruptured intracranial aneurysms in adults", PLoS One, 3, pp.e3691~ (2008)
  27. Biffi A, "Variants at APOE influence risk of deep and lobar intracerebral hemorrhage", Ann Neurol, 68, pp.934~943 (2010)
  28. Biffi A, "APOE genotype and extent of bleeding and outcome in lobar intracerebral haemorrhage: a genetic association study", Lancet Neurol, 10, pp.702~709 (2011)
  29. Maxwell SS, "Genetic associations with brain microbleeds: Systematic review and meta-analyses", Neurology, 77, pp.158~167 (2011)
  30. Yamada M, "Cerebral amyloid angiopathy in the aged", J Neurol, 234, pp.371~376 (1987)
  31. Pearson TA, "How to interpret a genome-wide association study", JAMA, 299, pp.1335~1344 (2008)
  32. Kubo M, "A nonsynonymous SNP in PRKCH (protein kinase C eta) increases the risk of cerebral infarction", Nat Genet, 39, pp.212~217 (2007)
  33. Serizawa M, "Association between PRKCH gene polymorphisms and subcortical silent brain infarction", Atherosclerosis, 199, pp.340~345 (2008)
  34. Wu L, "The 1425G", A SNP in PRKCH is associated with ischemic stroke and cerebral hemorrhage in a Chinese population, 2009, pp.40, 2973~2976
  35. Traylor M, "Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies", Lancet Neurol, 11, pp.951~962 (2012)
  36. Bevan S, "Genetic heritability of ischemic stroke and the contribution of previously reported candidate gene and genomewide associations", Stroke, 43, pp.3161~3167 (2012)
  37. Debette S, "Genome-wide association studies of MRI-defined brain infarcts: meta-analysis from the CHARGE Consortium", Stroke, 41, pp.210~217 (2010)
  38. Fornage M, "Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium", Ann Neurol, 69, pp.928~939 (2011)
  39. Woo D, "Meta-analysis of genome-wide association studies identifies 1q22 as a susceptibility locus for intracerebral hemorrhage", Am J Hum Genet, 94, pp.511~521 (2014)
  40. Joutel A, "Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia", Nature, 383, pp.707~710 (1996)
  41. 최재철, "Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy: A Genetic Cause of Cerebral Small Vessel Disease", Journal of Clinical Neurology, 6(1), pp.1~9 (2010), 대한신경과학회
  42. Chabriat H, "Clinical spectrum of CADASIL: a study of 7 families.Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy", Lancet, 346, pp.934~939 (1995)
  43. Dichgans M, "The phenotypic spectrum of CADASIL: clinical findings in 102 cases", Ann Neurol, 44, pp.731~739 (1998)
  44. Desmond DW, "The natural history of CADASIL: a pooled analysis of previously published cases", Stroke, 30, pp.1230~1233 (1999)
  45. Choi JC, "Diversity of stroke presentation in CADASIL: study from patients harboring the predominant NOTCH3 mutation R544C", J Stroke Cerebrovasc Dis, 22, pp.126~131 (2013)
  46. Singhal S, "The influence of genetic and cardiovascular risk factors on the CADASIL phenotype", Brain, 127, pp.2031~2038 (2004)
  47. Valenti R, "Psychiatric disturbances in CADASIL: a brief review", Acta Neurol Scand, 118, pp.291~295 (2008)
  48. Dichgans M, "Angiographic complications in CADASIL", Lancet, 349, pp.776~777 (1997)
  49. Feuerhake F, "Reversible coma with raised intracranial pressure: an unusual clinical manifestation of CADASIL", Acta Neuropathol, 103, pp.188~192 (2002)
  50. Chabriat H, "Cadasil", Lancet Neurol, 8, pp.643~653 (2009)
  51. van den Boom R, "Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy : MR imaging findings at different ages--3rd-6th decades", Radiology, 229, pp.683~690 (2003)
  52. Chabriat H, "Patterns of MRI lesions in CADASIL", Neurology, 51, pp.452~457 (1998)
  53. O’Sullivan M, "MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL", Neurology, 56, pp.628~634 (2001)
  54. De Guio F, "Loss of venous integrity in cerebral small vessel disease: a 7-T MRI study in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)", Stroke, 45, pp.2124~2126 (2014)
  55. Artavanis-Tsakonas S, "Notch signaling : cell fate control and signal integration in development", Science, 284, pp.770~776 (1999)
  56. Joutel A, "The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients", J Clin Invest, 105, pp.597~605 (2000)
  57. Alva JA, "Notch signaling in vascular morphogenesis", Curr Opin Hematol, 11, pp.278~283 (2004)
  58. Tikka S, "Congruence between NOTCH3 mutations and GOM in 131 CADASIL patients", Brain, 132, pp.933~939 (2009)
  59. Schmidt H, "Genetic variants of the NOTCH3 gene in the elderly and magnetic resonance imaging correlates of age-related cerebral small vessel disease", Brain, 134, pp.3384~3397 (2011)
  60. Razvi SS, "The prevalence of cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) in the west of Scotland", J Neurol Neurosurg Psychiatry, 76, pp.739~741 (2005)
  61. Dong Y, "Yield of screening for CADASIL mutations in lacunar stroke and leukoaraiosis", Stroke, 34, pp.203~205 (2003)
  62. Hara K, "Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease", N Engl J Med, 360, pp.1729~1739 (2009)
  63. Fukutake T, "Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL): from discovery to gene identification", J Stroke Cerebrovasc Dis, 20, pp.85~93 (2011)
  64. Nozaki H, "Features of cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy", Stroke, 45, pp.3447~3457 (2014)
  65. Bianchi S, "Two novel HTRA1 mutations in a European CARASIL patient", Neurology, 82, pp.898~900 (2014)
  66. Mendioroz M, "A missense HTRA1 mutation expands CARASIL syndrome to the Caucasian population", Neurology, 75, pp.2033~2035 (2010)
  67. Gould DB, "Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly", Science, 308, pp.1167~1171 (2005)
  68. Gould DB, "Role of COL4A1 in small-vessel disease and hemorrhagic stroke", N Engl J Med, 354, pp.1489~1496 (2006)
  69. Sibon I, "COL4A1 mutation in Axenfeld-Rieger anomaly with leukoencephalopathy and stroke", Ann Neurol, 62, pp.177~184 (2007)
  70. Lanfranconi S, "COL4A1 mutations as a monogenic cause of cerebral small vessel disease: a systematic review", Stroke, 41, pp.e513~518 (2010)
  71. Emanuel BS, "Localization of the human procollagen alpha 1(IV) gene to chromosome 13q34by in situ hybridization", Am J Hum Genet, 38, pp.38~44 (1986)
  72. Kuo DS, "COL4A1 and COL4A2 mutations and disease: insights into pathogenic mechanisms and potential therapeutic targets", Hum Mol Genet, 21, pp.R97~110 (2012)
  73. Grand MG, "Cerebroretinal vasculopathy. A new hereditary syndrome", Ophthalmology, 95, pp.649~659 (1988)
  74. Jen J, "Hereditary endotheliopathy with retinopathy, nephropathy, and stroke (HERNS)", Neurology, 49, pp.1322~1330 (1997)
  75. Terwindt GM, "Clinical and genetic analysis of a large Dutch family with autosomal dominant vascular retinopathy, migraine and Raynaud’s phenomenon", Brain, 121(Pt 2), pp.303~316 (1998)
  76. Ophoff RA, "Hereditary vascular retinopathy, cerebroretinal vasculopathy, and hereditary endotheliopathy with retinopathy, nephropathy, and stroke map to a single locus on chromosome 3p21.1-p21.3", Am J Hum Genet, 69, pp.447~453 (2001)
  77. Richards A, "C-terminal truncations in human 3’-5’ DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy", Nat Genet, 39, pp.1068~1070 (2007)
  78. Crow YJ, "Mutations in the gene encoding the 3’-5’ DNA exonuclease TREX1 cause Aicardi-Goutieres syndrome at the AGS1 locus", Nat Genet, 38, pp.917~920 (2006)
  79. Brady RO, "Enzymatic abnormalities in diseases of sphingolipid metabolism", Clin Chem, 13, pp.565~577 (1967)
  80. Houge G, "Fabry disease--a diagnostic and therapeutic challenge", Tidsskr Nor Laegeforen, 125, pp.1004~1006 (2005)
  81. Meikle PJ, "Prevalence of lysosomal storage disorders", JAMA, 281, pp.249~254 (1999)
  82. Shi Q, "Prevalence of Fabry disease in stroke patients--a systematic review and meta-analysis", J Stroke Cerebrovasc Dis, 23, pp.985~992 (2014)
  83. Mitsias P, "Cerebrovascular complications of Fabry’s disease", Ann Neurol, 40, pp.8~17 (1996)
  84. Crutchfield KE, "Quantitative analysis of cerebral vasculopathy in patients with Fabry disease", Neurology, 50, pp.1746~1749 (1998)
  85. Moore DF, "Increased signal intensity in the pulvinar on T1-weighted images: a pathognomonic MR imaging sign of Fabry disease", AJNR Am J Neuroradiol, 24, pp.1096~1101 (2003)
  86. Kraft P, "Beyond odds ratios--communicating disease risk based on genetic profiles", Nat Rev Genet, 10, pp.264~269 (2009)
  87. Malik R, "Multilocus genetic risk score associates with ischemic stroke in case-control and prospective cohort studies", Stroke, 45, pp.394~402 (2014)
  88. Ibrahim-Verbaas CA, "Predicting stroke through genetic risk functions: the CHARGE Risk Score Project", Stroke, 45, pp.403~412 (2014)
  89. El Dib RP, "Enzyme replacement therapy for Anderson-Fabry disease", Cochrane Database Syst Rev, 2, pp.CD006663~ (2013)
  90. Park JH, "Estimation of effect size distribution from genome-wide association studies and implications for future discoveries.", Nat Genet, 42, pp.570~575 (2010)
  91. Battey TW, "Recommendations From the International Stroke Genetics Consortium, Part 2: Biological Sample Collection and Storage", Stroke, 46, pp.285~290 (2015)
  92. Majersik JJ, "Recommendations From the International Stroke Genetics Consortium, Part 1: Standardized Phenotypic Data Collection", Stroke, 46, pp.279~284 (2015)
  94. Joutel A, "Cerebral small vessel disease : insights and opportunities from mouse models of collagen IV-related small vessel disease and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy", Stroke, 45, pp.1215~1221 (2014)

관련 논문AI추천

Association between Intracranial Arterial Dolichoectasia and Cerebral Small Vessel Disease and Its Underlying MechanismsBo Song, Dan Li, Dao Pei Zhang, Huai Liang Zhang, Jia Xu Liang, Suo Yin대한뇌졸중학회 · 대한뇌졸중영문학회지2020 · 제22권 제2호Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy: A Genetic Cause of Cerebral Small Vessel Disease최재철대한신경과학회 · Journal of Clinical Neurology2010 · 제6권 제1호Stroke Genetics: A Review and UpdateArne Lindgren대한뇌졸중학회 · 대한뇌졸중영문학회지2014 · 제16권 제3호Cerebral Small Vessel Disease: A Review Focusing on Pathophysiology, Biomarkers, and Machine Learning StrategiesAndrew Nicolaides, Angel Ois Santiago, Elisa Cuadrado-Godia, Harman S. Suri, Jasjit S. Suri, Jaume Roquer Gonzalez, John Laird, Luca Saba, Mercedes Balcells, Monika Turk, Narendra N. Khanna, Pratistha Dwivedi, Sanjiv Sharma대한뇌졸중학회 · 대한뇌졸중영문학회지2018 · 제20권 제3호Updates on Prevention of Hemorrhagic and Lacunar StrokesEric Jouvent, Hsin-Hsi Tsai, Jong S. Kim, M. Edip Gurol대한뇌졸중학회 · 대한뇌졸중영문학회지2018 · 제20권 제2호Prognostic Impact of Cerebral Small Vessel Disease on Stroke Outcome이승훈, Beom Joon Kim대한뇌졸중학회 · 대한뇌졸중영문학회지2015 · 제17권 제2호

이 간행물의 다른 논문 (14건)

Small Vessel Disease: Not a Small ProblemJong S. Kimpp. 1-1Lacunar Infarction and Small Vessel Disease: Pathology and PathophysiologyLouis R Caplanpp. 2-6Cerebral Amyloid Angiopathy: Emerging ConceptsMasahito Yamadapp. 17-30Cerebral Small Vessel Disease and Chronic Kidney DiseaseKazunori Toyodapp. 31-37Case Characteristics, Hyperacute Treatment, and Outcome Information from the Clinical Research Center for Stroke-Fifth Division Registry in South Korea김대현, 이준, 김재국, 김준태, 조용진, 조기현, 김욱주, 최재철, 박상순, 박종무, 오미선, 박태환, 신동익, 이경복, 홍정호, 윤병우, 고영채, 이수주, 김동억, 배희준, 김범준, 여민주, 손성일, 차재관, Ji Sung Lee, 한문구, 강규식, 류위선, 홍근식, 나현욱, 이준영, 유경호, 이병철pp. 38-53
원문 보기